Using clinical data and data on gene expression in MM cells that were collected during the HOVON65/GMMG-HD4 trial (series GSE19784) and stored in the GEO database, a public functional genomics data repository, we evaluated the relationship between expression of NCAM and the efficacy of Btz-containing therapy [24]. Here, CASC3 is linked to Miyoshi myopathy.